Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring the pharmacokinetics, drug-likeness, and toxicological features of anticancer flavonoids: a Boulevard to explore their clinical translational potential.

Frontiers in pharmacology·2025

Same author

Adenovirus-Based Single-Dose Vaccines for SARS-CoV-2: A Review.

Frontiers in bioscience (Landmark edition)·2025

Same author

Correction: Chavda et al. Peptide-Drug Conjugates: A New Hope for Cancer Management. <i>Molecules</i> 2022, <i>27</i>, 7232.

Molecules (Basel, Switzerland)·2025

Same author

Control measures for neglected tropical diseases: vaccine updates.

Expert review of vaccines·2025

Same author

Pseudopregnancy: when the body mimics pregnancy without a fetus.

International journal of surgery (London, England)·2025

Same author

Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. <i>Molecules</i> 2022, <i>27</i>, 4315.

Molecules (Basel, Switzerland)·2025

Search research articles

Related Experiment Video

Updated: Aug 9, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Interventional nanotheranostics in hepatocellular carcinoma.

Vivek P Chavda¹, Pankti C Balar², Srushti B Patel³

¹Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad, India.

Nanotheranostics

|February 16, 2023

Summary

Interventional nanotheranostics combines diagnosis and therapy for efficient disease management. This advanced drug delivery system, using nanoparticles, shows promise for treating diseases like Hepatocellular Carcinoma with minimal side effects.

Keywords:

HCC Interventional Nanotheranostics Liver Cancer Nanoparticle SELEX

More Related Videos

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Experiment Videos

Last Updated: Aug 9, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Area of Science:

Biomedical Engineering
Nanotechnology
Oncology

Background:

Interventional nanotheranostics integrates diagnostic and therapeutic capabilities for enhanced disease management.
Current limitations in disease detection and treatment necessitate innovative approaches.
Nanoparticles offer potential for targeted drug delivery and improved therapeutic outcomes.

Purpose of the Study:

To review the role and potential of interventional nanotheranostics in disease treatment.
To highlight the application of nanotheranostics in managing Hepatocellular Carcinoma.
To discuss the mechanisms, advantages, and challenges of nanotheranostic systems.

Main Methods:

Review of current literature on interventional nanotheranostics.
Analysis of nanoparticle-based drug delivery systems (e.g., Gold NPs, Carbon NPs, Silicon NPs).
Examination of diagnostic imaging integration with therapeutic delivery.

Main Results:

Nanotheranostics enables early disease detection, targeted drug delivery, and reduced damage to healthy tissues.
The system demonstrates high efficiency in disease management, particularly for Hepatocellular Carcinoma.
Identified pitfalls in current systems and proposed nanotheranostics as a superior alternative.

Conclusions:

Interventional nanotheranostics represents a significant advancement in precision medicine.
Despite current challenges, nanotheranostics holds substantial promise for future therapeutic applications.
Further research and development are crucial to overcome existing hindrances and realize the full potential of this technology.